Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Relationship Between Balance, Arm Function and Body Awareness in People With Stroke

11 de junho de 2026 atualizado por: Ozlem Yuruk, Baskent University

Investigation of Balance, Upper Extremity and Body Awareness in Individuals With Stroke

Stroke is one of the leading causes of long-term disability worldwide and is frequently associated with impairments in balance, upper extremity function, and body awareness. These impairments may negatively affect independence in activities of daily living and overall quality of life. Although previous studies have investigated the relationships between balance and upper extremity function after stroke, body awareness has received relatively limited attention.

The aim of this observational cross-sectional study is to investigate the relationship between balance, upper extremity skills, and body awareness in individuals with chronic stroke. Fifty-three individuals with chronic stroke will be recruited from the Department of Physical Medicine and Rehabilitation at Baskent University Hospital.

Balance will be assessed using the Berg Balance Scale and the Tetrax computerized posturography system. Upper extremity motor impairment and functional performance will be evaluated using the Fugl-Meyer Upper Extremity Assessment and the Wolf Motor Function Test. Body awareness will be assessed using the Body Awareness Questionnaire. Additional assessments will include lower extremity motor function, muscle tone, cognitive status, shoulder range of motion, and upper extremity reaction time.

The study is expected to provide a better understanding of the relationships among balance, upper extremity function, and body awareness in individuals with chronic stroke. The findings may contribute to the development of individualized rehabilitation strategies and improve clinical assessment approaches in stroke rehabilitation.

Visão geral do estudo

Status

Ainda não está recrutando

Descrição detalhada

Stroke is one of the leading causes of mortality and long-term disability worldwide and continues to represent a major public health problem. Motor, sensory, perceptual, and cognitive impairments that occur following stroke frequently result in limitations in functional independence and participation in daily life activities. Among these impairments, balance disorders and upper extremity dysfunction are particularly common and may significantly affect quality of life and rehabilitation outcomes.

Balance impairment after stroke is associated with postural instability, altered weight distribution, impaired trunk control, and an increased risk of falls. Changes in muscle tone, muscle weakness, impaired motor control, and deficits in sensory processing may negatively influence both static and dynamic balance. In addition, upper extremity impairments are observed in a large proportion of individuals with stroke and often persist into the chronic stage. Due to the complexity of upper extremity movements and the development of learned non-use, recovery of upper extremity function is generally slower and less complete than recovery of lower extremity function.

Previous studies have demonstrated associations between balance, trunk control, mobility, and upper extremity function in individuals with stroke. Impairments in upper extremity motor performance may influence postural control and balance strategies, while deficits in balance may limit functional use of the affected upper extremity. However, the interaction between these variables has not been fully clarified, particularly when functional upper extremity performance is evaluated using both clinical and objective measurement methods.

Body awareness has emerged as another important factor that may influence functional recovery following stroke. Body awareness is a multidimensional concept involving the perception and interpretation of bodily sensations, movements, and physiological states. It contributes to motor planning, movement execution, postural control, and interaction with the environment. Sensory deficits, perceptual disturbances, and motor impairments following stroke may negatively affect body awareness. Recent studies have suggested that body awareness may be associated with balance, walking ability, trunk control, upper extremity function, fear of falling, and independence in activities of daily living. Nevertheless, research examining body awareness in stroke populations remains limited.

A better understanding of the relationships among balance, upper extremity skills, and body awareness may provide valuable information for the development of individualized rehabilitation strategies. Identifying factors associated with functional performance may also contribute to the selection of appropriate assessment tools and treatment approaches in stroke rehabilitation.

The purpose of this observational cross-sectional study is to investigate the relationship between balance, upper extremity skills, and body awareness in individuals with chronic stroke. The study will be conducted at the Department of Physical Medicine and Rehabilitation, Baskent University Hospital. A total of 53 individuals with chronic stroke who meet the eligibility criteria will be included.

All assessments will be completed during a single evaluation session. Demographic and clinical information including age, sex, disease duration, dominant side, affected side, educational status, occupation, and use of assistive devices will be recorded.

Cognitive status will be assessed using the Standardized Mini-Mental State Examination (SMMSE), and only individuals scoring 24 points or higher will be included in the study. Muscle tone will be evaluated using the Modified Ashworth Scale, and only individuals with spasticity grades of 2 or 3 in the shoulder, elbow, wrist, and finger flexor muscles according to the Modified Ashworth Scale will be included in the study. Passive shoulder flexion range of motion will be measured using a goniometer, and only individuals with at least 120 degrees of shoulder flexion range of motion will be eligible for participation.

Upper and lower extremity motor impairment will be assessed using the Fugl-Meyer Assessment Scale. Upper extremity functional performance will be evaluated using the Wolf Motor Function Test.

Balance will be assessed using both clinical and objective measurement methods. Clinical balance performance will be evaluated using the Berg Balance Scale. Objective balance assessment will be performed using the Tetrax computerized posturography system, which provides measurements related to postural stability, weight distribution, and fall risk under different sensory conditions.

Upper extremity reaction time will be evaluated using the Light Trainer Flash Light Exercise System. Participants will be instructed to respond to randomly illuminated LED targets as quickly as possible, and the number of successful responses and reaction times will be recorded.

Body awareness will be assessed using the Body Awareness Questionnaire. Relationships among balance parameters, upper extremity motor and functional performance, reaction time, and body awareness scores will be analyzed using appropriate statistical methods.

Statistical analyses of the study data will be performed using SPSS software (Version 22.0). The obtained data will be expressed as mean ± standard deviation (x ± SD) and number (n%). Relationships among balance, upper extremity measurements, and body awareness will be evaluated using Pearson correlation analysis when data are normally distributed and Spearman rank correlation analysis when data are not normally distributed. In all analyses, the level of statistical significance will be accepted as p < 0.05.

Tipo de estudo

Observacional

Inscrição (Estimado)

53

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Estude backup de contato

Locais de estudo

    • Ankara
      • Ankara, Ankara, Turquia (Türkiye)
        • Baskent University Hospital
        • Investigador principal:
          • Zeliha Özlem YÜRÜK, Prof. Dr.
        • Subinvestigador:
          • Münire KILINÇ, MD
        • Contato:
        • Contato:
        • Investigador principal:
          • Tuğba DÖRTBÖLÜK, PT

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Adulto
  • Adulto mais velho

Aceita Voluntários Saudáveis

Não

Método de amostragem

Amostra Não Probabilística

População do estudo

Individuals with chronic stroke who are receiving outpatient follow-up and rehabilitation services at the Department of Physical Medicine and Rehabilitation, Baskent University Hospital.

Descrição

Inclusion Criteria:

  • Individuals who experienced a cerebrovascular event at least 6 months previously
  • Individuals between 18 and 75 years of age
  • Individuals who have experienced stroke for the first time
  • Individuals with shoulder, elbow, wrist, and finger muscle tone graded as 2 or 3 according to the Modified Ashworth Scale (MAS)
  • Individuals scoring 24 points or higher on the Standardized Mini Mental State Examination
  • Individuals with at least 120° of shoulder range of motion
  • Individuals who are able to walk independently or with a walking aid

Exclusion Criteria:

  • Presence of communication problems such as difficulties in reading, writing, or speaking
  • Botulinum toxin injection within the last 3 months
  • Presence of hemispatial neglect syndrome
  • Presence of ataxia due to posterior circulation ischemia
  • Bilateral involvement (bilateral hemiparesis)
  • Having received physiotherapy within the last 6 months
  • Presence of orthopedic problems such as shoulder subluxation, shoulder pain, contracture of the hand and wrist
  • History of upper extremity or thoracic surgery
  • Presence of stroke-related visual impairments (hemianopia)
  • Presence of color blindness
  • Use of antiepileptic medication
  • History of convulsions

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Berg Balance Scale Score
Prazo: Baseline (single assessment)
To assess balance performance, the Berg Balance Scale (BBS) will be used. The scale consists of 14 functional tasks including sitting to standing, transfers, turning, reaching forward, picking up an object from the floor, and standing on one leg. Each item is scored from 0 to 4. Total scores range from 0 to 56, with higher scores indicating better balance performance.
Baseline (single assessment)
Tetrax Fall Index
Prazo: Baseline (single assessment)
To assess fall risk the Tetrax Computerized Posturography System will be used. Measurements will be performed under eight different sensory conditions. The Fall Index ranges from 0 to 100, with higher scores indicating a greater risk of falling.
Baseline (single assessment)
Eyes Open Stability Index
Prazo: Baseline (single assessment)
To assess postural stability under eyes-open conditions, the Tetrax Computerized Posturography System will be used. The Stability Index obtained during the normal standing position with eyes open will be recorded. Higher values indicate poorer postural stability.
Baseline (single assessment)
Eyes Closed Stability Index
Prazo: Baseline (single assessment)
To assess postural stability without visual input, participants will stand on the Tetrax Computerized Posturography System with their eyes closed. The Stability Index obtained during this condition will be recorded. Higher values indicate poorer postural stability.
Baseline (single assessment)
Weight Distribution Index
Prazo: Baseline (single assessment)
To assess weight distribution during standing, the Tetrax Computerized Posturography System will be used. The Weight Distribution Index will be recorded. Higher values indicate greater asymmetry in weight distribution between the supporting surfaces.
Baseline (single assessment)
Fugl-Meyer Upper Extremity Assessment Score
Prazo: Baseline (single assessment)
To assess upper extremity motor impairment, the Fugl-Meyer Upper Extremity Assessment will be used. The scale evaluates reflex activity, voluntary movement, coordination, and speed. Scores range from 0 to 66, with higher scores indicating better upper extremity motor function.
Baseline (single assessment)
Wolf Motor Function Test Functional Ability Score
Prazo: Baseline (single assessment)
Upper extremity functional ability will be assessed using the Functional Ability Scale of the Wolf Motor Function Test (WMFT). Fifteen functional tasks will be evaluated and scored on a scale from 0 to 5, with higher scores indicating better upper extremity function.
Baseline (single assessment)
Wolf Motor Function Test Performance Time
Prazo: Baseline (single assessment)
Upper extremity motor performance will be assessed using the Wolf Motor Function Test (WMFT). The average time required to complete the 15 functional tasks will be recorded in seconds. Shorter completion times indicate better upper extremity performance.
Baseline (single assessment)
Body Awareness Questionnaire Score
Prazo: Baseline (single assessment)
To assess body awareness, the Body Awareness Questionnaire will be used. The questionnaire consists of 18 items evaluating awareness of bodily processes and reactions. Total scores range from 18 to 126, with higher scores indicating greater body awareness.
Baseline (single assessment)

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Upper Extremity Reaction Time
Prazo: Baseline (single assessment)
Upper extremity reaction time will be assessed using the Light Trainer Flash Light Exercise System. Participants will be instructed to deactivate illuminated LED targets as quickly as possible during a 60-second test. The average time required to deactivate the illuminated targets will be recorded. Shorter reaction times indicate better performance.
Baseline (single assessment)
Fugl-Meyer Lower Extremity Assessment Score
Prazo: Baseline (single assessment)
Lower extremity motor function will be assessed using the Fugl-Meyer Lower Extremity Assessment. The scale consists of 17 items evaluating movement, coordination, and motor performance of the lower extremity. Total scores range from 0 to 34, with higher scores indicating better lower extremity motor function.
Baseline (single assessment)

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Investigadores

  • Investigador principal: Zeliha Özlem O YÜRÜK, Baskent University Hospital, Department of Physical Medicine and Rehabilitation

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

20 de junho de 2026

Conclusão Primária (Estimado)

20 de agosto de 2026

Conclusão do estudo (Estimado)

20 de outubro de 2026

Datas de inscrição no estudo

Enviado pela primeira vez

5 de junho de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

11 de junho de 2026

Primeira postagem (Real)

17 de junho de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

17 de junho de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

11 de junho de 2026

Última verificação

1 de junho de 2026

Mais Informações

Termos relacionados a este estudo

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever